Comments
Bayer seeks FDA approval for cancer drug radium-223
15.12.2012. | FRANKFURT (Reuters) - German drugmaker Bayer said on Friday it requested approval from U.S. regulators for an experimental prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales....
